COST-EFFECTIVENESS ANALYSIS OF OCTREOTIDE LAR VERSUS LANREOTIDE SR FOR THE TREATMENT OF PATIENTS WITH ACTIVE ACROMEGALY IN CHINA
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1065
https://www.valueinhealthjournal.com/article/S1098-3015(16)01133-5/fulltext
Title :
COST-EFFECTIVENESS ANALYSIS OF OCTREOTIDE LAR VERSUS LANREOTIDE SR FOR THE TREATMENT OF PATIENTS WITH ACTIVE ACROMEGALY IN CHINA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01133-5&doi=10.1016/j.jval.2016.03.1065
First page :
A248
Section Title :
Systemic Disorders/Conditions - Cost Studies
Open access? :
No
Section Order :
912